Navigation Links
Cardium Completes $6.0 Million Financing
Date:11/10/2008

ngina. For more information about Cardium Therapeutics and its businesses, products and therapeutic candidates, please visit http://www.cardiumthx.com or view its 2007 Annual Report at http://www.cardiumthx.com/flash/pdf/CardiumAR07_Book_FINAL.pdf.

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that human clinical trials can be conducted and completed in an efficient and successful manner, that partnering opportunities can be successfully achieved and that such opportunities will effectively and efficiently advance commercialization of our products, that product modifications or launches will be successful or that the resulting products will be favorably received in the marketplace, that results or trends observed in one clinical study will be reproduced in subsequent studies, that our products or product candidates will prove to be sufficiently safe and effective, that necessary regulatory approvals will be obtained, or that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive. Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and therapeutic hypothermia devices and in the conduct of human clinical trials, including the timing,
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. An international first at the CHUM - Promising treatment in regeneration of the myocardium through the use of stem cells
2. Cardium Reports on Recent Highlights and Financial Results
3. Cardiums InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
4. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
5. Eligard(R) six-month formulation successfully completes European approval procedure
6. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
9. GSI Securitization Completes Merger and Domicile Transfer
10. Medical Services International Inc. Completes Testing for European Union (EU) Application
11. Inverness Completes Acquisition of Cholestech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... The city of San Diego, California, because ... with a plan to recycle wastewater – also called ... supports the San Diego plan as part of her ... Kleyne, by recycling water that San Diego already owns, ... greatly reduced. (Spagat, E, “San Diego looks to sewers ...
(Date:11/26/2014)... 26, 2014 GI for Life announced ... reductions in prices of their popular nutritional supplements: ... D3 . Discounts of 40% will be offered ... for Life’s proprietary ColoVite supplement is a scientifically formulated ... colon health. One easy-to-take colon vitamin with ALL the ...
(Date:11/26/2014)... NY (PRWEB) November 26, 2014 Call ... research requirements or email the details on sales(at)researchmoz(dot)us ... diabetes and drug discovery market 2014" with deep study ... is the result of high blood sugar. The global ... directly linked to the growing number of diabetics in ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 News ... showcase expanded capabilities at RSNA 2014 in Chicago. ... manage and share diagnostic images, photos, videos and ... Perceptive’s booth #8107 will learn more about these ... acquired technologies and partner initiatives – that enable ...
(Date:11/26/2014)... Teens prescribed anti-anxiety or sleep medications are much ... teens, a new study warns. The findings ... on teenagers before prescribing these drugs to them, ... realize the abuse potential," said lead researcher Carol ... School of Nursing. "These drugs produce highly attractive ...
Breaking Medicine News(10 mins):Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2
... Shared genes point to interbreeding with modern humans , THURSDAY, ... of the Neanderthal, Homo sapiens , closest evolutionary relative, ... makes humans uniquely human. , As it turns out, 1 ... outside of Africa was probably inherited from Neanderthals, apparently because ...
... after timing change, researchers say , THURSDAY, May 6 (HealthDay ... vitamin D supplement if you take it with your largest ... examined 17 patients with vitamin D deficiency who weren,t getting ... months, the patients were told to take vitamin D supplements ...
... from Cold Spring Harbor Laboratory in the USA have developed ... tumor cells. The breakthrough allows them to study in fine ... potential to help doctors identify dangerous tumor cells from small ... non-invasive lesion in the breast. Dr James Hicks from ...
... Maria Mandalakas, MD, MSEpi, associate professor of Pediatrics, ... Western Reserve University School of Medicine, has been ... Board to receive a 2010 U.S. Fulbright Scholarship. ... 11 months in Tygerberg, South Africa in collaboration ...
... comes to talking to parents about most dating issues, teen girls ... to talk to their mothers. However, a new study found ... and what they do with their dates while unsupervised. And in ... mothers than they were their fathers. Results showed that ...
... ... Americans struggling to find steady employment in a highly competitive market. In order to gain ... a more youthful, refreshed appearance. Non-surgical med spa treatments can offer many benefits during a ... (PRWEB) May ...
Cached Medicine News:Health News:Scientists Map Neanderthal Genome 2Health News:Scientists Map Neanderthal Genome 3Health News:Genome breakthrough allows scientists to identify and profile tumor cells from very small samples 2Health News:CWRU global TB expert receives prestigious Fulbright Scholar Award 2Health News:CWRU global TB expert receives prestigious Fulbright Scholar Award 3Health News:Teen girls talk more to parents about their dating habits than do boys 2Health News:Teen girls talk more to parents about their dating habits than do boys 3Health News:Med Spa Treatments Become More Popular as Unemployment Rates Climb 2Health News:Med Spa Treatments Become More Popular as Unemployment Rates Climb 3
(Date:11/26/2014)... , Nov. 26, 2014  BioScrip ® , Inc. (NASDAQ: ... President and Chief Executive Officer, will present at the Bank of ... , , , Date: , , , Wednesday, December 3, ... p.m. EST , , , , Location: , , , ... About BioScrip, Inc. BioScrip, Inc. is ...
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
(Date:11/26/2014)... Nov. 26, 2014  Aridis Pharmaceuticals, Inc., a ... therapies for infectious diseases, announced today the addition ... recognized key opinion leader in the areas of ... board. Founder and Chief Executive Officer, ... Dr. Opal,s extensive experience investigating bacterial toxins and ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
... 1064 nm Nd:YAG Base Platform ... ophthalmologists treating the anterior segment ... the elimination of secondary cataracts ... Selecta platform offers multiple upgrade ...
... The Alliance Catheter Delivery System ... and stabilization of the Aescula ... CDS has a patented coronary ... quick and easy access to ...
... system is Haemonetics latest ... of plasma and flexible ... collection of "jumbo" units ... plasma with optional saline ...
Optipress II Automated Blood Component Extractor for the standardized separation of whole blood into high purity individual components...
Medicine Products: